An Updated Meta-analysis and System Review:is Gemcitabine+Fluoropyrimidine in Combination a Better Therapy Versus Gemcitabine Alone for Advanced and Unresectable Pancreatic Cancer?

Tu ,  Chao ,  Zheng 외 7명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

Systemic Chemotherapy in Advanced Pancreatic Cancer

Hee Seung Lee ,  박승우

Gut and Liver

2016 .01

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer

이경훈 ,  지의규 ,  임석아 외 10명

Cancer Research and Treatment

2021 .10

Establishment of a Pancreatic Cancer Stem Cell Model Using the SW1990 Human Pancreatic Cancer Cell Line in Nude Mice

Pan ,  Yan ,  Gao 외 5명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

Pancreatic Cancer

Wooil Kwon

대한외과학회 학술대회 초록집

2021 .11

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study

우상명 ,  김민경 ,  주정남 외 11명

Cancer Research and Treatment

2017 .01

Molecular Mechanism of Capsaicin in Pancreatic Cancer Prevention and Therapy

SANJAY K. SRIVASTAVA

대한동의병리학회 학술대회논문집

2015 .10

Current status of pancreatic cancer treatment in China

Wenhui LOU

Annals of Hepato-Biliary-Pancreatic Surgery

2022 .12

Gemcitabine and Erlotinib with or without Oxaliplatin in Previously Untreated Advanced Pancreatic Cancer: A Randomized Phase II Trial

문종호 ,  임성희 ,  윤진아 외 11명

Yonsei Medical Journal

2021 .01

Preoperative treatment for pancreatic cancer

Ch ,  istophe ,  L. Wolfgang

대한외과학회 학술대회 초록집

2016 .11

Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer

성민제 ,  방승민

대한췌담도학회지

2020 .01

Comparison of Single Agent Gemcitabine and Docetaxel in Second-Line Therapy for Advanced Stage Non-Small Cell Lung Cancer in a University Hospital in Turkey

Yildi ,  im ,  Fatma 외 8명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer

임재윤 ,  조장호 ,  이세준 외 3명

Cancer Research and Treatment

2015 .01

MCT4 as a potential therapeutic target to augment gemcitabine chemosensitivity in resected pancreatic cancer

Sung Hwan LEE ,  Ho Kyoung HWANG ,  Woo Jung LEE 외 1명

Annals of Hepato-Biliary-Pancreatic Surgery

2021 .12

20대 젊은 남자에서 발병한 췌장암

백승호 ,  이승수 ,  김지훈 외 4명

대한내과학회지

2020 .02

A Case of Five-Year Survival in Metastatic Pancreatic Cancer

박현정 ,  이광혁 ,  이종균 외 3명

대한췌담도학회지

2024 .07

전이 췌장암 환자의 Gemcitabine과 방암탕 가감방 및 건칠단 병용투여 치험 1례

김은혜 ,  윤성수 ,  이지영 외 1명

대한암한의학회지

2018 .01

Surgical Treatment for Elderly Patients with Pancreatic Cancer

Sun Whe Kim

대한외과학회 학술대회 초록집

2022 .11

In vitro Study of the Antagonistic Effect of Low-dose Liquiritigenin on Gemcitabine-induced Capillary Leak Syndrome in Pancreatic Adenocarcinoma via Inhibiting ROS-Mediated Signalling Pathways

Wu ,  Wei ,  Xia 외 7명

Asian Pacific journal of cancer prevention : APJCP

2015 .01

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines

문성웅 ,  김진원 ,  성지해 외 9명

Cancer Research and Treatment

2015 .01